nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC16A3—optic choroid—melanoma	0.0567	0.325	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—skin of body—melanoma	0.0166	0.0954	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—mammalian vulva—melanoma	0.0152	0.087	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—eye—melanoma	0.0114	0.0654	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—retina—melanoma	0.0113	0.0648	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—mammalian vulva—melanoma	0.00864	0.0495	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lymph node—melanoma	0.0076	0.0436	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—eye—melanoma	0.00693	0.0397	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—retina—melanoma	0.00687	0.0394	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—head—melanoma	0.00647	0.0371	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—head—melanoma	0.00618	0.0354	CbGeAlD
Gamma Hydroxybutyric Acid—GABRB1—head—melanoma	0.00497	0.0285	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—lymph node—melanoma	0.00453	0.026	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lymph node—melanoma	0.00433	0.0248	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—head—melanoma	0.00393	0.0225	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—lymph node—melanoma	0.00275	0.0158	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—ITGB1—melanoma	0.00206	0.00684	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ARL2—melanoma	0.00197	0.00655	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00189	0.00628	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Vemurafenib—melanoma	0.00188	0.00359	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Dactinomycin—melanoma	0.00187	0.00356	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Vemurafenib—melanoma	0.00187	0.00356	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Vemurafenib—melanoma	0.00187	0.00356	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Vemurafenib—melanoma	0.00185	0.00353	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Bleomycin—melanoma	0.00184	0.0035	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00182	0.00604	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Carmustine—melanoma	0.00182	0.00346	CcSEcCtD
Gamma Hydroxybutyric Acid—Pollakiuria—Temozolomide—melanoma	0.0018	0.00342	CcSEcCtD
Gamma Hydroxybutyric Acid—Depression—Carmustine—melanoma	0.00179	0.00341	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—ITGB3—melanoma	0.00178	0.00593	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Weight increased—Temozolomide—melanoma	0.00177	0.00337	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—SDHD—melanoma	0.00176	0.00586	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—BSG—melanoma	0.00176	0.00586	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Weight decreased—Temozolomide—melanoma	0.00176	0.00335	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Temozolomide—melanoma	0.00175	0.00334	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Carmustine—melanoma	0.00175	0.00333	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Temozolomide—melanoma	0.00173	0.00331	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Temozolomide—melanoma	0.00173	0.00331	CcSEcCtD
Gamma Hydroxybutyric Acid—Depression—Temozolomide—melanoma	0.00173	0.0033	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00172	0.00328	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Dactinomycin—melanoma	0.00171	0.00326	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Temozolomide—melanoma	0.00169	0.00322	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Bleomycin—melanoma	0.00166	0.00316	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00165	0.00549	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Alopecia—Bleomycin—melanoma	0.00163	0.00311	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Temozolomide—melanoma	0.00163	0.0031	CcSEcCtD
Gamma Hydroxybutyric Acid—Hallucination—Carmustine—melanoma	0.0016	0.00305	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Carmustine—melanoma	0.0016	0.00305	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—MMP1—melanoma	0.0016	0.00532	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Vemurafenib—melanoma	0.00159	0.00304	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Carmustine—melanoma	0.00159	0.00302	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.00159	0.00527	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Carmustine—melanoma	0.00158	0.00302	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Vemurafenib—melanoma	0.00155	0.00296	CcSEcCtD
Gamma Hydroxybutyric Acid—Hallucination—Temozolomide—melanoma	0.00155	0.00295	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Temozolomide—melanoma	0.00155	0.00295	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Temozolomide—melanoma	0.00155	0.00294	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Dactinomycin—melanoma	0.00154	0.00294	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Temozolomide—melanoma	0.00154	0.00293	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.00153	0.0051	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema peripheral—Temozolomide—melanoma	0.00153	0.00292	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Temozolomide—melanoma	0.00153	0.00292	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.00153	0.00508	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urethral disorder—Temozolomide—melanoma	0.00153	0.00291	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Dactinomycin—melanoma	0.00152	0.0029	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Carmustine—melanoma	0.00151	0.00287	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain in extremity—Docetaxel—melanoma	0.0015	0.00285	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00149	0.00496	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00149	0.00494	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anaemia—Bleomycin—melanoma	0.00149	0.00283	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Vemurafenib—melanoma	0.00148	0.00282	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00148	0.00491	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—FN1—melanoma	0.00146	0.00485	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Eye disorder—Temozolomide—melanoma	0.00146	0.00277	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Temozolomide—melanoma	0.00145	0.00277	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Temozolomide—melanoma	0.00145	0.00275	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00144	0.00478	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Vemurafenib—melanoma	0.00143	0.00273	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Carmustine—melanoma	0.00142	0.00271	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Temozolomide—melanoma	0.00141	0.00269	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Carmustine—melanoma	0.00141	0.00269	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Docetaxel—melanoma	0.00141	0.00268	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Temozolomide—melanoma	0.00141	0.00268	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Temozolomide—melanoma	0.0014	0.00267	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Carmustine—melanoma	0.0014	0.00267	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Temozolomide—melanoma	0.0014	0.00266	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Docetaxel—melanoma	0.00139	0.00265	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00139	0.00461	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anaemia—Dactinomycin—melanoma	0.00139	0.00264	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Vemurafenib—melanoma	0.00138	0.00262	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Temozolomide—melanoma	0.00138	0.00262	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Bleomycin—melanoma	0.00137	0.00261	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Bleomycin—melanoma	0.00137	0.00261	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Docetaxel—melanoma	0.00137	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Vemurafenib—melanoma	0.00136	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Temozolomide—melanoma	0.00136	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Vemurafenib—melanoma	0.00136	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Carmustine—melanoma	0.00136	0.00259	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Vemurafenib—melanoma	0.00136	0.00258	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Temozolomide—melanoma	0.00136	0.00258	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00135	0.00257	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CEACAM1—melanoma	0.00134	0.00447	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Docetaxel—melanoma	0.00134	0.00255	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Temozolomide—melanoma	0.00133	0.00253	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—ITGA4—melanoma	0.00133	0.00441	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—CD44—melanoma	0.00133	0.00441	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCB5—melanoma	0.00132	0.0044	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Confusional state—Bleomycin—melanoma	0.00132	0.00252	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Carmustine—melanoma	0.00132	0.00252	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Docetaxel—melanoma	0.00132	0.00252	CcSEcCtD
Gamma Hydroxybutyric Acid—Tremor—Carmustine—melanoma	0.00131	0.0025	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Bleomycin—melanoma	0.00131	0.0025	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Temozolomide—melanoma	0.00131	0.0025	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC6A11—melanoma	0.0013	0.00434	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Bleomycin—melanoma	0.0013	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Carmustine—melanoma	0.0013	0.00247	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Carmustine—melanoma	0.00129	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Vemurafenib—melanoma	0.00129	0.00245	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Temozolomide—melanoma	0.00128	0.00243	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Dactinomycin—melanoma	0.00128	0.00243	CcSEcCtD
Gamma Hydroxybutyric Acid—Tremor—Temozolomide—melanoma	0.00127	0.00242	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Temozolomide—melanoma	0.00125	0.00239	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Bleomycin—melanoma	0.00125	0.00238	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Temozolomide—melanoma	0.00125	0.00237	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—ITGAV—melanoma	0.00122	0.00407	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Dactinomycin—melanoma	0.00122	0.00233	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Temozolomide—melanoma	0.00122	0.00232	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Carmustine—melanoma	0.00122	0.00232	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Dactinomycin—melanoma	0.00122	0.00232	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—BSG—melanoma	0.00121	0.00404	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypertension—Carmustine—melanoma	0.00121	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2A—melanoma	0.0012	0.00399	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Palpitations—Temozolomide—melanoma	0.0012	0.00228	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Bleomycin—melanoma	0.00119	0.00228	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Carmustine—melanoma	0.00119	0.00228	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Carmustine—melanoma	0.00119	0.00228	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Carmustine—melanoma	0.00119	0.00227	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Bleomycin—melanoma	0.00118	0.00224	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Docetaxel—melanoma	0.00118	0.00224	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNA5—melanoma	0.00118	0.00391	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Convulsion—Temozolomide—melanoma	0.00117	0.00224	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00117	0.0039	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Weight decreased—Docetaxel—melanoma	0.00117	0.00223	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Temozolomide—melanoma	0.00117	0.00223	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Bleomycin—melanoma	0.00117	0.00223	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Dactinomycin—melanoma	0.00117	0.00222	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Carmustine—melanoma	0.00115	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Temozolomide—melanoma	0.00115	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Temozolomide—melanoma	0.00115	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Docetaxel—melanoma	0.00115	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Docetaxel—melanoma	0.00115	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Temozolomide—melanoma	0.00115	0.00219	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00115	0.00218	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Carmustine—melanoma	0.00114	0.00218	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—FLNA—melanoma	0.00114	0.0038	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Bleomycin—melanoma	0.00114	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Carmustine—melanoma	0.00114	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—SLC6A11—melanoma	0.00113	0.00376	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dry mouth—Temozolomide—melanoma	0.00113	0.00215	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Docetaxel—melanoma	0.00112	0.00214	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Bleomycin—melanoma	0.00112	0.00214	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Temozolomide—melanoma	0.00112	0.00213	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00111	0.00212	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—ITGB1—melanoma	0.00111	0.00369	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Temozolomide—melanoma	0.00111	0.00211	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Temozolomide—melanoma	0.0011	0.00209	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Carmustine—melanoma	0.00109	0.00208	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Docetaxel—melanoma	0.00109	0.00207	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Temozolomide—melanoma	0.00108	0.00207	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Bleomycin—melanoma	0.00108	0.00206	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Temozolomide—melanoma	0.00107	0.00205	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—PIK3CB—melanoma	0.00107	0.00356	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Temozolomide—melanoma	0.00107	0.00204	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ARL2—melanoma	0.00106	0.00354	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Dactinomycin—melanoma	0.00106	0.00203	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Dactinomycin—melanoma	0.00105	0.00201	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Temozolomide—melanoma	0.00105	0.00201	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Dactinomycin—melanoma	0.00105	0.00199	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Carmustine—melanoma	0.00104	0.00199	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Bleomycin—melanoma	0.00104	0.00199	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Docetaxel—melanoma	0.00104	0.00198	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Carmustine—melanoma	0.00104	0.00197	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CLU—melanoma	0.00103	0.00343	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Docetaxel—melanoma	0.00103	0.00196	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Carmustine—melanoma	0.00103	0.00196	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Docetaxel—melanoma	0.00103	0.00196	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Docetaxel—melanoma	0.00102	0.00195	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Carmustine—melanoma	0.00102	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Docetaxel—melanoma	0.00102	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Carmustine—melanoma	0.00102	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Docetaxel—melanoma	0.00102	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Docetaxel—melanoma	0.00102	0.00193	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—RHOB—melanoma	0.00101	0.00336	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ACER3—melanoma	0.00101	0.00335	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Dactinomycin—melanoma	0.00101	0.00192	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Temozolomide—melanoma	0.00101	0.00192	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Temozolomide—melanoma	0.001	0.00191	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Dactinomycin—melanoma	0.001	0.00191	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Carmustine—melanoma	0.000995	0.0019	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Temozolomide—melanoma	0.000993	0.00189	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Carmustine—melanoma	0.000988	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Temozolomide—melanoma	0.000986	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Temozolomide—melanoma	0.000983	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Carmustine—melanoma	0.000979	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Carmustine—melanoma	0.000979	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Temozolomide—melanoma	0.000974	0.00186	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Docetaxel—melanoma	0.000968	0.00184	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Dactinomycin—melanoma	0.000967	0.00184	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Bleomycin—melanoma	0.000966	0.00184	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—ITGB3—melanoma	0.000963	0.0032	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Temozolomide—melanoma	0.000962	0.00183	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Docetaxel—melanoma	0.000961	0.00183	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Temozolomide—melanoma	0.000955	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Temozolomide—melanoma	0.000954	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Temozolomide—melanoma	0.000946	0.0018	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Temozolomide—melanoma	0.000946	0.0018	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Carmustine—melanoma	0.000943	0.0018	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Bleomycin—melanoma	0.000941	0.00179	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Docetaxel—melanoma	0.000939	0.00179	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Carmustine—melanoma	0.000936	0.00178	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Docetaxel—melanoma	0.000935	0.00178	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Docetaxel—melanoma	0.000933	0.00178	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Docetaxel—melanoma	0.000929	0.00177	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—UGT2B10—melanoma	0.000922	0.00307	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ARL2—melanoma	0.000918	0.00305	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Alopecia—Docetaxel—melanoma	0.000915	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Temozolomide—melanoma	0.000912	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Docetaxel—melanoma	0.000907	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—RAC2—melanoma	0.000906	0.00301	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Carmustine—melanoma	0.000905	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Temozolomide—melanoma	0.000905	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Docetaxel—melanoma	0.000901	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000901	0.003	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Dactinomycin—melanoma	0.000901	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—VEGFC—melanoma	0.000892	0.00296	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dysgeusia—Docetaxel—melanoma	0.000883	0.00168	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Temozolomide—melanoma	0.000879	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Dactinomycin—melanoma	0.000878	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Temozolomide—melanoma	0.000875	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Docetaxel—melanoma	0.000872	0.00166	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Docetaxel—melanoma	0.000867	0.00165	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—MMP1—melanoma	0.000864	0.00287	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HS3ST5—melanoma	0.000858	0.00285	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Carmustine—melanoma	0.000843	0.00161	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Dactinomycin—melanoma	0.000837	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Bleomycin—melanoma	0.000834	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Docetaxel—melanoma	0.000833	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Bleomycin—melanoma	0.000827	0.00158	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Bleomycin—melanoma	0.000826	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—NRAS—melanoma	0.000825	0.00274	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Carmustine—melanoma	0.000821	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Temozolomide—melanoma	0.000815	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Docetaxel—melanoma	0.000808	0.00154	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000806	0.00268	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Palpitations—Docetaxel—melanoma	0.000797	0.00152	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Temozolomide—melanoma	0.000794	0.00151	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Docetaxel—melanoma	0.000792	0.00151	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—FN1—melanoma	0.000788	0.00262	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Carmustine—melanoma	0.000783	0.00149	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SPARC—melanoma	0.000783	0.0026	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—F2R—melanoma	0.000783	0.0026	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Convulsion—Docetaxel—melanoma	0.000781	0.00149	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Bleomycin—melanoma	0.000779	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Docetaxel—melanoma	0.000778	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Dactinomycin—melanoma	0.000778	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000776	0.00258	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Dactinomycin—melanoma	0.000771	0.00147	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Docetaxel—melanoma	0.000767	0.00146	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Docetaxel—melanoma	0.000767	0.00146	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Docetaxel—melanoma	0.000767	0.00146	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000762	0.00145	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Carmustine—melanoma	0.000757	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Temozolomide—melanoma	0.000757	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000755	0.00251	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dry mouth—Docetaxel—melanoma	0.000751	0.00143	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Docetaxel—melanoma	0.000742	0.00141	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Docetaxel—melanoma	0.000736	0.0014	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HSPA5—melanoma	0.000733	0.00244	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Temozolomide—melanoma	0.000732	0.00139	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Docetaxel—melanoma	0.000731	0.00139	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Carmustine—melanoma	0.000728	0.00139	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Dactinomycin—melanoma	0.000727	0.00138	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Docetaxel—melanoma	0.000724	0.00138	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Carmustine—melanoma	0.000722	0.00138	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Docetaxel—melanoma	0.000721	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Carmustine—melanoma	0.000721	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Carmustine—melanoma	0.000717	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—GAB2—melanoma	0.000716	0.00238	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—GNA11—melanoma	0.000716	0.00238	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Skin disorder—Docetaxel—melanoma	0.000715	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—KRAS—melanoma	0.00071	0.00236	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—SLC-mediated transmembrane transport—ALB—melanoma	0.000708	0.00236	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000705	0.00234	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Temozolomide—melanoma	0.000703	0.00134	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Docetaxel—melanoma	0.000701	0.00134	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Temozolomide—melanoma	0.000698	0.00133	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Temozolomide—melanoma	0.000697	0.00133	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000695	0.00231	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Temozolomide—melanoma	0.000693	0.00132	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—GRIN2A—melanoma	0.000691	0.0023	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Carmustine—melanoma	0.00068	0.0013	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HDAC2—melanoma	0.000673	0.00224	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Docetaxel—melanoma	0.00067	0.00128	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000669	0.00223	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—GNAQ—melanoma	0.000666	0.00221	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CD44—melanoma	0.000666	0.00221	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ITGA4—melanoma	0.000666	0.00221	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Insomnia—Docetaxel—melanoma	0.000665	0.00127	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNB1—melanoma	0.000661	0.0022	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Docetaxel—melanoma	0.000661	0.00126	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Temozolomide—melanoma	0.000657	0.00125	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—BSG—melanoma	0.000656	0.00218	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Docetaxel—melanoma	0.000656	0.00125	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Docetaxel—melanoma	0.000654	0.00125	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—PIK3CA—melanoma	0.000653	0.00217	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PLCB4—melanoma	0.00065	0.00216	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Docetaxel—melanoma	0.000648	0.00123	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNA1—melanoma	0.000645	0.00214	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Docetaxel—melanoma	0.00064	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA5—melanoma	0.000635	0.00211	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Docetaxel—melanoma	0.000635	0.00121	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Docetaxel—melanoma	0.000634	0.00121	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.000634	0.00211	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCA—melanoma	0.00063	0.00209	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pain—Docetaxel—melanoma	0.000629	0.0012	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Docetaxel—melanoma	0.000629	0.0012	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SYK—melanoma	0.000626	0.00208	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—FLNA—melanoma	0.000617	0.00205	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—AKT3—melanoma	0.000614	0.00204	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ITGAV—melanoma	0.000614	0.00204	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC6A11—melanoma	0.000611	0.00203	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIP4K2A—melanoma	0.000611	0.00203	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000608	0.00202	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Docetaxel—melanoma	0.000606	0.00116	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Cell surface interactions at the vascular wall—HRAS—melanoma	0.000604	0.00201	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Docetaxel—melanoma	0.000602	0.00115	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IFNA2—melanoma	0.0006	0.00199	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000597	0.00198	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MTAP—melanoma	0.000594	0.00198	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Docetaxel—melanoma	0.000582	0.00111	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CB—melanoma	0.000578	0.00192	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ABCB1—melanoma	0.000576	0.00191	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—SLC-mediated transmembrane transport—ALB—melanoma	0.00056	0.00186	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CLU—melanoma	0.000558	0.00185	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ITGB1—melanoma	0.000558	0.00185	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—RHOB—melanoma	0.000546	0.00181	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ACER3—melanoma	0.000545	0.00181	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Docetaxel—melanoma	0.000542	0.00103	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PHGDH—melanoma	0.00053	0.00176	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—LUM—melanoma	0.00053	0.00176	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Docetaxel—melanoma	0.000528	0.00101	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HPSE—melanoma	0.00052	0.00173	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HGF—melanoma	0.00051	0.0017	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CUBN—melanoma	0.00051	0.0017	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CSF2—melanoma	0.000504	0.00168	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Docetaxel—melanoma	0.000503	0.000959	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—UGT2B10—melanoma	0.000498	0.00166	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SDHD—melanoma	0.000493	0.00164	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CSPG4—melanoma	0.000493	0.00164	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—BSG—melanoma	0.000493	0.00164	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—RAC2—melanoma	0.000489	0.00163	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Docetaxel—melanoma	0.000486	0.000927	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ITGB3—melanoma	0.000484	0.00161	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PRKCA—melanoma	0.000484	0.00161	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—VEGFC—melanoma	0.000482	0.0016	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GPAM—melanoma	0.000477	0.00159	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—PRKCA—melanoma	0.000473	0.00157	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Docetaxel—melanoma	0.000468	0.000891	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Docetaxel—melanoma	0.000464	0.000884	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—melanoma	0.000464	0.00154	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dermatitis—Docetaxel—melanoma	0.000463	0.000883	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HS3ST5—melanoma	0.000463	0.00154	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Docetaxel—melanoma	0.000461	0.000878	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ABCB1—melanoma	0.000455	0.00151	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—RAC1—melanoma	0.000448	0.00149	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—NRAS—melanoma	0.000446	0.00148	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Docetaxel—melanoma	0.000437	0.000833	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MMP1—melanoma	0.000434	0.00144	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CDK2—melanoma	0.000426	0.00142	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SPARC—melanoma	0.000423	0.00141	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—F2R—melanoma	0.000423	0.00141	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PLA2G6—melanoma	0.000406	0.00135	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—FN1—melanoma	0.000396	0.00132	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HSPA5—melanoma	0.000396	0.00132	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NOS2—melanoma	0.000391	0.0013	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	0.000389	0.00129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GNA11—melanoma	0.000387	0.00129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GAB2—melanoma	0.000387	0.00129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—melanoma	0.000384	0.00128	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CG—melanoma	0.000379	0.00126	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—EGF—melanoma	0.000374	0.00124	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—VCAN—melanoma	0.000364	0.00121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HDAC2—melanoma	0.000364	0.00121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—PRKCA—melanoma	0.000363	0.00121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—ALB—melanoma	0.00036	0.0012	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GNAQ—melanoma	0.000359	0.0012	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CD44—melanoma	0.000359	0.0012	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITGA4—melanoma	0.000359	0.0012	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNB1—melanoma	0.000357	0.00119	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—melanoma	0.000352	0.00117	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PLCB4—melanoma	0.000351	0.00117	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—BRAF—melanoma	0.000349	0.00116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA1—melanoma	0.000348	0.00116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IGF1—melanoma	0.000347	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SYK—melanoma	0.000338	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CD—melanoma	0.000333	0.00111	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITGAV—melanoma	0.000332	0.0011	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—AKT3—melanoma	0.000332	0.0011	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC6A11—melanoma	0.00033	0.0011	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIP4K2A—melanoma	0.00033	0.0011	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ALB—melanoma	0.000329	0.00109	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—HRAS—melanoma	0.000326	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IFNA2—melanoma	0.000324	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000322	0.00107	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTAP—melanoma	0.000321	0.00107	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP17A1—melanoma	0.000307	0.00102	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—SLC-mediated transmembrane transport—ALB—melanoma	0.000302	0.00101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITGB1—melanoma	0.000301	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—MDM2—melanoma	0.000292	0.000971	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GNA11—melanoma	0.00029	0.000965	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CB—melanoma	0.00029	0.000965	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PHGDH—melanoma	0.000286	0.000951	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—LUM—melanoma	0.000286	0.000951	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—ALB—melanoma	0.000285	0.000946	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—FASN—melanoma	0.000284	0.000944	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HPSE—melanoma	0.000281	0.000933	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC5A5—melanoma	0.000279	0.000929	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000278	0.000924	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HGF—melanoma	0.000276	0.000916	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CUBN—melanoma	0.000275	0.000916	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CSF2—melanoma	0.000272	0.000906	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GNAQ—melanoma	0.00027	0.000897	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CD44—melanoma	0.00027	0.000897	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—BRAF—melanoma	0.000267	0.000888	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IL2—melanoma	0.000267	0.000886	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SDHD—melanoma	0.000266	0.000884	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CSPG4—melanoma	0.000266	0.000884	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—BSG—melanoma	0.000266	0.000884	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	0.000266	0.000883	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITGB3—melanoma	0.000261	0.000868	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PRKCA—melanoma	0.000261	0.000868	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP1B1—melanoma	0.000259	0.00086	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GPAM—melanoma	0.000258	0.000856	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000246	0.000817	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—RAC1—melanoma	0.000242	0.000805	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MMP1—melanoma	0.000234	0.000779	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CDK2—melanoma	0.00023	0.000764	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—VEGFA—melanoma	0.000227	0.000753	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—MDM2—melanoma	0.000224	0.000744	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NRAS—melanoma	0.000224	0.000744	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PLA2G6—melanoma	0.000219	0.000728	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MAPK3—melanoma	0.000214	0.000713	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—FN1—melanoma	0.000214	0.000711	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	0.000213	0.000709	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCB1—melanoma	0.000213	0.000708	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000212	0.000705	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NOS2—melanoma	0.000211	0.000702	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CG—melanoma	0.000205	0.00068	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—MAPK1—melanoma	0.000204	0.000678	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—EGF—melanoma	0.000202	0.000672	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—MAPK1—melanoma	0.0002	0.000664	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—VCAN—melanoma	0.000197	0.000654	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PRKCA—melanoma	0.000196	0.000652	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ERCC2—melanoma	0.000194	0.000647	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—KRAS—melanoma	0.000193	0.00064	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IGF1—melanoma	0.000187	0.000623	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CD—melanoma	0.00018	0.000598	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ALB—melanoma	0.000178	0.00059	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CA—melanoma	0.000177	0.000588	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TP53—melanoma	0.000171	0.000569	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP17A1—melanoma	0.000166	0.000552	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—HRAS—melanoma	0.000164	0.000544	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—HRAS—melanoma	0.00016	0.000533	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GNA11—melanoma	0.000157	0.000521	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CB—melanoma	0.000157	0.000521	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ALB—melanoma	0.000154	0.000511	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CG—melanoma	0.000154	0.000511	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—FASN—melanoma	0.000153	0.00051	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—MAPK1—melanoma	0.000153	0.000509	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC5A5—melanoma	0.000151	0.000502	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PPARG—melanoma	0.000148	0.000493	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GNAQ—melanoma	0.000146	0.000485	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CD44—melanoma	0.000146	0.000485	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—AKT1—melanoma	0.000145	0.000481	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL2—melanoma	0.000144	0.000479	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP1B1—melanoma	0.00014	0.000465	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CD—melanoma	0.000135	0.000449	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ALB—melanoma	0.000133	0.000443	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ALB—melanoma	0.000133	0.000441	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—HRAS—melanoma	0.000123	0.000408	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—VEGFA—melanoma	0.000122	0.000407	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NRAS—melanoma	0.000121	0.000402	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CB—melanoma	0.000118	0.000391	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS2—melanoma	0.000117	0.000388	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MAPK3—melanoma	0.000116	0.000385	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCB1—melanoma	0.000115	0.000383	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—MAPK1—melanoma	0.00011	0.000366	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PRKCA—melanoma	0.000106	0.000352	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ERCC2—melanoma	0.000105	0.000349	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—KRAS—melanoma	0.000104	0.000346	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTEN—melanoma	0.000102	0.000338	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CA—melanoma	9.56e-05	0.000318	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TP53—melanoma	9.24e-05	0.000307	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—HRAS—melanoma	8.84e-05	0.000294	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CG—melanoma	8.29e-05	0.000276	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PPARG—melanoma	8.01e-05	0.000266	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—AKT1—melanoma	7.81e-05	0.00026	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CD—melanoma	7.29e-05	0.000242	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ALB—melanoma	7.2e-05	0.000239	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CA—melanoma	7.17e-05	0.000239	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CB—melanoma	6.36e-05	0.000211	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS2—melanoma	6.3e-05	0.000209	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—AKT1—melanoma	5.86e-05	0.000195	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTEN—melanoma	5.49e-05	0.000183	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CA—melanoma	3.87e-05	0.000129	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AKT1—melanoma	3.16e-05	0.000105	CbGpPWpGaD
